Koyfin Home > Directory > Health Care > Keryx Biopharm Inc

Keryx Biopharm Inc Price Chart KERX

Historical daily share price chart and data for Keryx Biopharm Inc since 2000 adjusted for splits and dividends. The latest closing price for Keryx Biopharm Inc as of December 12, 2018 is $3.36.
  • In 2018 the stock opened at $4.68 and closed at $3.36 for a loss of -39%.
  • In 2017 the stock opened at $5.94 and closed at $4.65 for a loss of -28%.
  • In 2016 the stock opened at $4.91 and closed at $5.86 for a gain of 16%.
  • In 2015 the stock opened at $14.27 and closed at $5.05 for a loss of -183%.
View Chart On Koyfin

Keryx Biopharm Inc Summary

Stock Symbol: KERX

Keryx Biopharm Inc Company Info

Keryx Biopharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on providing medicines for patients with kidney disease in the United States. It markets its lead product Auryxia (ferric citrate), an orally available, absorbable, iron-based medicine for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis, as well as for the treatment of iron deficiency anemia in adults with CKD not on dialysis. The company has strategic alliances with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of ferric citrate in Japan; and with Panion & BF Biotech, Inc. for the development and marketing of ferric citrate. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in Boston, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
0 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of KERX Prices